Trials / Recruiting
RecruitingNCT06288503
Hydrolysed Rice Formula Study
A Double-blind, Randomised-controlled Trial Evaluating a Hydrolysed Rice Formula Compared to a Cow's Milk Protein-based Extensively Hydrolysed Formula in Infants With Cow's Milk Allergy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- Sponsor
- Nutricia UK Ltd · Industry
- Sex
- All
- Age
- 0 Months – 13 Months
- Healthy volunteers
- Not accepted
Summary
This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hydrolysed Rice Protein Formula | Infants randomised onto this arm will be taking the hydrolysed rice protein formula, with a minimum prescription of 30% of their energy requirements. |
| OTHER | Cow's Milk Based Extensively Hydrolysed Formula | Infants randomised onto this arm will be taking the control product, with a minimum prescription of 30% of their energy requirements. |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2027-07-01
- Completion
- 2027-07-01
- First posted
- 2024-03-01
- Last updated
- 2026-04-13
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06288503. Inclusion in this directory is not an endorsement.